Business Wire

ExaGrid Launches Version 6.2 with 5 Key Performance, Integration, and Security Features

15.11.2022 16:00:00 EET | Business Wire | Press release

Share

ExaGrid ®, the industry's only Tiered Backup Storage solution, today announced the release of software Version 6.2, which begins shipping in early December 2022.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221115005053/en/

ExaGrid is constantly driving improvements in five key areas: ingest performance for the fastest backups and shortest backup window, fastest restores to keep user productive, scalability to ensure a fixed-length backup window as data grows as well as no forklift upgrades and no planned product obsolescence, lowest cost up front and over time, and a strong security story including the ability to recover after a security attack such as ransomware.

ExaGrid's Unique Architecture employs:

  • Front-end disk-cache Landing Zone for fast backups
    • Optimized for large backup jobs, parallel backup support (job concurrency), no inline deduplication to slow backups down, encryption at the drive level to increase performance, and integrations with key backup applications for front-end load balancing.
    • Fast restores as the data is in the native backup application format and is non-deduplicated to avoid compute-intensive data rehydration
  • Scale-out architecture
    • Keeps a fixed-length backup window as data grows
    • Eliminates disruptive and costly forklift upgrades
    • Can mix and match any age and any size appliance eliminating planned product obsolescence to reduce costs over time
  • Non-network-facing Repository Tier
    • Deduplicated data to efficiently store all current and long-term retention data for cost savings
    • Not visible or accessible from the network
    • Delayed deletes to ensure data deleted on the front-end Landing Zone is not immediately deleted in the repository ensuring data is ready for recovery after an attack
    • Immutable data objects that are not deleted, changed, or modified to ensure recovery from encryption events

5 Key Updates in Version 6.2

Veritas NetBackup Single Target Storage Pool
ExaGrid has integrated with NetBackup and presents a single virtualized target pool of storage at each site. This approach automates job management between Veritas NetBackup and ExaGrid, where backup data is automatically sent to available ExaGrid appliances for front-end performance. Backup data is directed into any ExaGrid appliance as all ExaGrid appliances are in a single integrated scale-out system. ExaGrid automatically load balances all data across all non-network facing repositories for full storage utilization and globally deduplicates data across all repositories for maximum storage savings.

Veritas IT Analytics
ExaGrid has integrated with Veritas IT analytics, allowing reporting on key data statistics from the ExaGrid storage. This allows enterprises to include ExaGrid Tiered Backup storage along with unified insights for backup, storage, and virtual infrastructure.

ExaGrid, including Single Target Storage Pool and support of NetBackup Analytics, now has a total of 9 Veritas NetBackup integrations, including support of NetBackup Accelerator, OST Integration, integration with NetBackup media server hardware, AIR (Auto Image Replication), and GRT (granular level restore), optimized deduplication, and instant recovery.

New ExaGrid Cloud Tier Features and Integrations
ExaGrid physical appliances on premise in the data center can replicate data to the public clouds for disaster recovery (DR). ExaGrid has improved the performance and scalability of its ExaGrid Cloud Tier for Amazon AWS and has added ExaGrid Cloud Tier support for Microsoft Azure. ExaGrid physical on-site appliances replicate the deduplicated data in the repository to AWS or Azure, which is then written to AWS or Azure storage for long-term retention. The deduplicated data uses about 1/50th of the bandwidth versus undeduplicated data. ExaGrid encrypts the data in transit, and the cloud providers encrypt the data at rest.

Improved Performance
ExaGrid has improved its Adaptive Deduplication performance, increasing the Repository Tier's overall performance and further increasing the scalability and recovery points of data in the non-network-facing Repository Tier and offsite disaster recovery copy.

ExaGrid has greatly improved the performance of Veeam synthetic fulls (Veeam V12) by adding support for Veeam's Fast Clone technology in ExaGrid repositories. The synthetics fulls are at least 30X faster than previous versions.

Improved Security
ExaGrid has a strong ransomware recovery solution with a non-network-facing Repository Tier (tiered air gap), delayed delete policy, immutable data objects, and 2FA support. ExaGrid has added two new features:

  • An alert on large delete is generated as an early detection warning if a threat actor/hacker is trying to delete a large amount of recently ingested data (above a set operational threshold) on the ExaGrid front-end Landing Zone.
  • An alert on data deduplication change is generated when the deduplication ratio changes below a set threshold signaling that a large amount of encrypted data is being sent to the ExaGrid front-end Landing Zone or that the data on the Landing Zone is being encrypted.

These features add an early alert warning in addition to the current ExaGrid Retention Time-Lock (RTL) functionality, ensuring that the data in the non-network-facing tier is available for recovery.

"ExaGrid continues to focus on improving backup and restore performance, scalability, cost savings, and security," said Bill Andrews, CEO of ExaGrid. "Since ExaGrid is 100% focused on backup storage, all we do is obsess about making backup storage better. We are the only company worldwide focusing solely on backup storage. It is a testament to the product that we are installed in over 80 countries worldwide, have 99% of our customers on yearly maintenance and support contracts, have a NPS of +81, and a customer retention rate of 95%. All of these numbers are market-leading in storage. ExaGrid is a financially healthy and growing company that is cash positive, P&L positive, and EBITDA positive. The combination of our product, customer support, and financial strength is why customers trust ExaGrid Tiered Backup Storage."

About ExaGrid
ExaGrid provides Tiered Backup Storage with a unique disk-cache Landing Zone, long-term retention repository, and scale-out architecture. ExaGrid's Landing Zone provides for the fastest backups, restores, and instant VM recoveries. The retention repository offers the lowest cost for long-term retention. ExaGrid's scale-out architecture includes full appliances and ensures a fixed-length backup window as data grows, eliminating expensive forklift upgrades and product obsolescence. ExaGrid offers the only two-tiered backup storage approach with a non-network-facing tier, delayed deletes, and immutable objects to recover from ransomware attacks.

ExaGrid has physical sales and pre-sales systems engineers in the following countries: Argentina, Australia, Benelux, Brazil, Canada, Chile, CIS, Colombia, Czech Republic, France, Germany, Hong Kong, Iberia, India, Israel, Japan, Mexico, Nordics, Poland, Saudi Arabia, Singapore, South Africa, South Korea, Turkey, United Arab Emirates, United Kingdom, United States, and other regions.

Visit us at exagrid.com or connect with us on LinkedIn . See what our customers have to say about their own ExaGrid experiences and learn why they now spend significantly less time on backup in our customer success stories . Check out our 100+ Gartner Peer Insight Reviews . ExaGrid is proud of our +81 NPS score.

ExaGrid is a registered trademark of ExaGrid Systems, Inc. All other trademarks are the property of their respective holders.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media:
Mary Domenichelli
ExaGrid
mdomenichelli@exagrid.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye